Abogen Biosciences, Novartis, ABO2203, mRNA, RNA Therapeutics, T-Cell Engager, CD19xCD3, Autoimmune Diseases, B-Cell Depletion, Immunotherapy, Biopharma

China, October 2, 2026 Abogen Biosciences has announced a major licensing and option agreement with Novartis to advance innovative...